iCrowd Newswire
13 May 2022, 12:18 GMT+10
Rise in initiatives from government for large-scale sequencing projects drives the growth of the global RNA based therapeutics market. On the other hand, hurdles in drug delivery, high cost of research, and threats of failure restrain the growth to some extent. However, early commercialization of pipeline therapeutics is expected to create lucrative opportunities in the industry.
The global RNA based therapeutics industry was estimated at $4.93 billion in 2021, and is anticipated to hit $25.12 billion by 2030, registering a CAGR of 17.6% from 2021 to 2030.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/546
The increase in number of patients suffering from chronic diseases, further fuels the growth of the global RNA Based Therapeutics market.
The RNA based therapeutics has been explored as a promising treatment option for the diseases which are difficult to treat. Development of this therapeutics is based on promising technologies such as RNA interference technology (RNAi), antisense technology. Moreover, Cancer diagnosis and treatment is currently undergoing a shift with the incorporation of RNAi techniques in personalized medicine and molecular diagnostics, also for the diagnostic purposes, small interfering RNAs (siRNA) or microRNAs (miRNA) can be utilized.
Impact of COVID-19 on RNA Based Therapeutics Market- There was a steep decline in the number of patients visiting clinics and hospitals for RNA based therapies, which, in turn, decreased the demand for RNA based therapeutic products, especially during the initial phase of the pandemic. This impacted the global RNA based therapeutic market negatively.
Get detailed COVID-19 impact analysis on the RNA Based Therapeutic Market- https://www.alliedmarketresearch.com/request-for-customization/546?reqfor=covid
Depending on by type, the market is divided into RNA interference (RNAi) and RNA antisense. RNA antisense segment is projected to show fastest growth during the forecast period, owing to increase in revenue of RNA antisense drug discovery and therapeutics.
This report provides comprehensive competitive analysis and profiles of prominent market players such as Alnylam Pharmaceuticals, Inc., Silence Therapeutics plc, Arbutus Biopharma Corporation, Genzyme (Sanofi), Ionis Pharmaceuticals, Sarepta Therapeutics, Benitec Biopharma Inc, Arrowhead Pharmaceuticals, Biogen, Inc and Gradalis, Inc.
Key Findings of the Study:
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with vario research data tables and confirms utmost accuracy in our market forecasting. Each and ever us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Tags: RNA based therapeutics industry, RNA based therapeutics market
See Campaign: https://www.alliedmarketresearch.com/rna-based-therapeutics-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Tags:Reportedtimes, Financial Content, PR-Wirein, Research Newswire, EnglishGet a daily dose of Denver Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Denver Sun.
More InformationSAN FRANCISCO, California: In a letter released this week, the archbishop of San Francisco, Salvatore Cordileone, said U.S. House Speaker ...
BERLIN, Germany: At least 43 people were injured after a tornado struck the western German city of Paderborn on May ...
WASHINGTON D.C.: The Department of Justice has said that an American citizen and four Chinese intelligence officers have been charged ...
WASHINGTON D.C.: Due to the inability of businesses to hire enough workers, the U.S. has announced that it will grant ...
WASHINGTON D.C.: U.S. senators Elizabeth Warren and Mike Rounds have introduced a bipartisan resolution requesting the Federal Trade Commission (FTC) ...
MOSCOW, Russia: According to preliminary data released by the finance ministry this week, almost three months after Moscow's invasion of ...
SACRAMENTO, California: In another blow to the state's push to diversify corporate leadership, a California court judge has ruled that ...
Pete Alonso's three-run homer capped a five-run third inning Monday night as the visiting New York Mets rolled to a ...
Nazem Kadri scored a hat trick to lift the visiting Avalanche past the St. Louis Blues 6-3 on Monday, giving ...
Yoshi Tsutsugo's tiebreaking RBI infield single in the eighth inning Monday gave the Pittsburgh Pirates a 2-1 win over the ...
The Golden State Warriors look to become the first team since Michael Jordan's Chicago Bulls to make six trips to ...
The Minnesota Timberwolves finalized a five-year deal with Denver Nuggets president of basketball operations Tim Connelly to have him lead ...